Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Compound Western medicine for treating pertussis

A technology of whooping cough and western medicine, applied in antibacterial drugs, drug combinations, pharmaceutical formulas, etc., can solve the problems of large side effects, etc., and achieve the effects of quick onset, stable action, and no toxic side effects

Inactive Publication Date: 2017-04-26
ZHENGZHOU RENHONG PHARMA CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the above-mentioned drugs have certain curative effect in treating pertussis, they have great side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A compound western medicine for treating pertussis, the main raw materials in parts by weight are: 5 parts of camelliaside A, 3 parts of palmatine, 20 parts of demethyl gentianoside, and dioscolide 8 parts of B, 2 parts of ginkgo biloba, 1 part of isomangiferin, 10 parts of menthol, 23 parts of campesterol, 2 parts of 5-hydroxyp-naphthoquinone, and 2 parts of sanguinarine citrate.

[0016] A preparation method of compound western medicine for treating pertussis, the specific steps are:

[0017] First of all, in a pharmaceutical-grade clean area, according to the above metering ratio, weigh and take camelliaside A, palmatine, demethyl daisy leaf gentianoside, arrowroot diosconolide B, ginkgo biflavanone, iso Mangiferin, menthol, campesterol, 5-hydroxyp-naphthoquinone, sanguinarine citrate, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4min, control RSD≤5%, After mixing, it is pressed into tablets and dried at a low temper...

Embodiment 2

[0019] A compound western medicine for treating pertussis, the main raw materials in parts by weight are: 8 parts of camelliaside A, 4 parts of palmatine red alkali, 22 parts of demethyl gentianoside, and dioscolide 9 parts of B, 2 parts of ginkgo biloba, 1 part of isomangiferin, 12 parts of menthol, 25 parts of campesterol, 2 parts of 5-hydroxyp-naphthoquinone, and 2 parts of sanguinarine citrate.

[0020] A preparation method of compound western medicine for treating pertussis, the specific steps are:

[0021] First of all, in a pharmaceutical-grade clean area, according to the above metering ratio, weigh and take camelliaside A, palmatine, demethyl daisy leaf gentianoside, arrowroot diosconolide B, ginkgo biflavanone, iso Mangiferin, menthol, campesterol, 5-hydroxyp-naphthoquinone, sanguinarine citrate, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4min, control RSD≤5%, After mixing, it is pressed into tablets and dried at a...

Embodiment 3

[0023] A compound western medicine for treating pertussis, the main raw materials in parts by weight are: 10 parts of camelliaside A, 5 parts of palmatine red alkali, 24 parts of demethyl gentianone glycosides, and arrowroot dioscolide 10 parts of B, 3 parts of ginkgo biloba, 2 parts of isomangiferin, 13 parts of menthol, 26 parts of campesterol, 4 parts of 5-hydroxyp-naphthoquinone, and 3 parts of sanguinarine citrate.

[0024] A preparation method of compound western medicine for treating pertussis, the specific steps are:

[0025] First of all, in a pharmaceutical-grade clean area, according to the above metering ratio, weigh and take camelliaside A, palmatine, demethyl daisy leaf gentianoside, arrowroot diosconolide B, ginkgo biflavanone, iso Mangiferin, menthol, campesterol, 5-hydroxyp-naphthoquinone, sanguinarine citrate, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 6 minutes, controlled RSD ≤ 5%, After mixing, it is pre...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound Western medicine for treating pertussis. The compound Western medicine is prepared from the following main raw materials in parts by weight: 5-15 parts of camellianin A, 3-7 parts of palmatrubine, 20-30 parts of norswertianolin, 8-12 parts of taccalonolide B, 2-4 parts of ginkgetin, 1-3 parts of isomangiferin, 10-15 parts of menthol, 23-30 parts of campesterol, 2-5 parts of 5-hydroxy-p-naphthoquinone, and 2-4 parts of sanguinarine citrate. According to the compound Western medicine, the raw materials are strictly selected according to the knowing mechanism for pertussis, so that the purpose of comprehensive rehabilitation is achieved, and in addition, the compound Western medicine has the advantages of being rapid in taking effect, stable in effect, convenient to carry and take, and free of toxic and side effects after long-term administration.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to a compound western medicine for treating pertussis. Background technique [0002] Whooping cough is a common acute respiratory infectious disease in children, and Bacillus pertussis is the pathogenic bacteria of this disease. It is characterized by paroxysmal spasmodic cough, accompanied by a special inspiratory roar at the end of the cough, and the course of the disease is long, up to several weeks or even 3 months, so it is called pertussis. When infants suffer from this disease, they are prone to complications such as suffocation, pneumonia, and encephalopathy, and the fatality rate is high. In recent years, the incidence of infants and adults has increased, and 40% of the fatal cases are infants and young children within 5 months. Early treatment with antibiotics generally leads to a good prognosis. The disease spreads all over the world, is generally sporadic, and can ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K31/352A61K31/045A61K31/575A61K31/122A61K31/4741A61K31/4375A61K31/585A61P11/14A61P31/04
CPCA61K31/045A61K31/122A61K31/352A61K31/4375A61K31/4741A61K31/575A61K31/585A61K31/7048A61K2300/00
Inventor 不公告发明人
Owner ZHENGZHOU RENHONG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com